Events

Videos

Podcasts

Articles

Clinical

® Clinical Focus page includes a listing of all specialities covered across  OncLive.com, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, hematologic malignancies, and gynecologic cancers. Each individual specialty page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances in both the localized and metastatic settings, and ongoing research.


Combination Therapies in Renal Cell Carcinoma  

Treating Non-Clear Cell Histologies of RCC

Dosing Schedule of Sunitinib in Renal Cell Carcinoma 

Pazopanib and Sunitinib in Renal Cell Carcinoma  

Treatment Options in Renal Cell Carcinoma  

The FDA issued a complete response letter to Telesta Therapeutics informing the company that its biologics license application for MCNA in bladder cancer would not be approved and that an additional phase III clinical trial was needed to adequately evaluate the immunotherapy. 

FDA Issues Complete Response Letter for Immunotherapy MCNA in Bladder Cancer

The second interim analysis of the phase III METEOR trial has revealed a statistically significant improvement in overall survival with cabozantinib (Cometriq) versus everolimus as a treatment for patients with advanced renal cell carcinoma following progression on one prior therapy.

Second-Line Cabozantinib Shows Rare Survival Advantage in RCC

Advancing Renal Cell Carcinoma

Vaccines for Renal Cell Carcinoma

Study Results: Lenvatinib in Renal Cell Carcinoma

PD-L1 Expression as a Biomarker in RCC

Trial Data on Cabozantinib in Renal Cell Carcinoma

Clinical Trial Data Review: Nivolumab Use in RCC

Predictive Tools in Renal Cell Carcinoma 

Selecting Second-Line Agents in Renal Cell Carcinoma 

Managing Disease Progression in RCC

Treating Non-Clear Cell Renal Cell Carcinoma 

Bone and Brain Metastases in Renal Cell Carcinoma

Dosing Sunitinib and Pazopanib in Renal Cell Carcinoma  

Reviewing Results from COMPARZ and PISCES Clinical Trials

Urothelial Cancer

The OncLive Urology condition center page is a comprehensive resource for clinical news and expert insights on urologic cancers, including prostate cancer, bladder cancer, testicular cancer, penile cancer, and renal cell carcinoma. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in brain cancer.

Prostate Cancer

The OncLive Prostate Cancer condition center page is a comprehensive resource for clinical news and expert insights on how to approach treatment for patients with nonmetastatic, castration-resistant, or castration-sensitive prostate cancer. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, ongoing research, and treatment advances with androgen receptor inhibitors, PARP inhibitors, and more in prostate cancer.

The OncLive Genitourinary Cancer condition center page is a comprehensive resource for clinical news and expert insights across genitourinary (GU) malignancies, including renal cell carcinoma, urothelial carcinoma, and prostate cancer. This section features news articles, interviews in written and video format, and podcasts that focus on the evolving treatment paradigm of GU cancers and emerging research. 